A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.
Saved in:
| Title: | A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease. |
|---|---|
| Authors: | Johnson SM; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. Steven.Johnson@unchealth.unc.edu., Haberberger J; Foundation Medicine, Inc, Cambridge, MA, USA., Galeotti J; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Ramkissoon L; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Coombs CC; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; UC Irvine, 1001 Health Sciences Road, Irvine, CA, 92697, USA., Richardson DR; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Foster MC; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Novartis Pharmaceuticals, Cambridge, MA, 02139, USA., Duncan D; Foundation Medicine, Inc, Cambridge, MA, USA.; GRAIL, Inc., 4001 E NC 54 Hwy Assembly Suite 1100, Durham, NC, 27709, USA., Zeidner JF; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Ferguson NL; Foundation Medicine, Inc, Cambridge, MA, USA., Montgomery ND; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Tempus Labs, Inc., 25 Alexandria Way, Durham, NC, 27703, USA. |
| Source: | Blood cancer journal [Blood Cancer J] 2023 Jun 26; Vol. 13 (1), pp. 96. Date of Electronic Publication: 2023 Jun 26. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-023-00876-w |
